SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-006383
Filing Date
2022-02-02
Accepted
2022-02-02 16:32:42
Documents
1
Period of Report
2022-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 15312
  Complete submission text file 0001209191-22-006383.txt   16651
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Issuer) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O UROGEN PHARMA LTD. 9 HA'TA'ASIYA STREET RA'ANANA L3 4365007
Business Address
Barrett Elizabeth A. (Reporting) CIK: 0001764157 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38079 | Film No.: 22584145